z-logo
open-access-imgOpen Access
Target/therapies for chronic recurrent erythema nodosum leprosum
Author(s) -
Pugazhenthan Thangaraju,
Shoban Babu Varthya,
Sajıtha Venkatesan
Publication year - 2020
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_788_19
Subject(s) - leprosy , erythema nodosum , medicine , dermatology , lepromatous leprosy , disease , immunology , complication , surgery
A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here